巨噬细胞靶向自组装纳米系统治疗牙周炎
本研究设计了一种巨噬细胞靶向的金属有机/多酚自组装纳米递药系统(ZCH NPs),通过CD44受体介导内吞靶向巨噬细胞,在酸性溶酶体环境(~pH5)下响应释放锌离子和姜黄素,经PPAR/Notch信号通路发挥抗炎免疫调节作用,并清除胞内外细菌、抑制生物膜形成,在大鼠实验性牙周炎中减轻炎症性骨吸收。
要点
- ZCH NPs经CD44受体靶向巨噬细胞,pH响应释放锌离子和姜黄素。
- 双释放通过PPAR/Notch通路发挥抗炎与免疫调节作用。
- 大鼠牙周炎中CEJ-ABC距离从~568降至~250 µm,减轻骨吸收。
核心结论
- ZCH NPs通过现场响应性递药,在牙周炎治疗中展现优越疗效,为感染相关慢性炎症疾病提供有前景的策略。
研究设计与样本
- 设计并合成透明质酸功能化、负载姜黄素的沸石咪唑酯骨架-8纳米颗粒(ZCH NPs),并在大鼠实验性牙周炎模型中评价疗效。
主要发现
- ZCH NPs经CD44受体介导内吞选择性靶向巨噬细胞,在~pH5酸性溶酶体环境下降解释放锌离子和姜黄素。
- 双释放通过PPAR/Notch信号通路发挥抗炎和免疫调节活性。
- ZCH NPs在炎症环境下恢复干细胞成骨潜能,并清除胞外和胞内细菌、抑制生物膜形成。
- 大鼠实验性牙周炎中,ZCH NPs减轻炎症性骨吸收,釉牙骨质界-牙槽嵴顶距离从~568降至~250 µm。
临床怎么用
- 该纳米系统通过清除致病菌、调节免疫反应和促进成骨分化,促进牙周组织再生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Periodontitis is a chronic inflammatory disease triggered by pathogenic bacteria, with intracellular bacteria and biofilm contributing to persistent periodontal inflammation. In this context, macrophages can be portrayed as a privileged niche for long-term bacterial colonization, leading to further disruption of the immune microenvironment rather than its modulation. Here, a macrophage-targeted metal-organic/polyphenol self-assembly nano drug delivery system was designed for on-site drug delivery and microenvironment restoration. The nanoparticles were synthesized by hyaluronic acid functionalization on the surface of curcumin (Cur)-loaded zeolitic imidazolate framework-8 (denoted as ZCH NPs). ZCH NPs selectively targeted macrophages through CD44 receptor-mediated endocytosis. Following cellular uptake, the nanoparticles underwent pH-responsive degradation in the acidic lysosomal environment (~pH5), releasing zinc ions and Cur. The dual release exerted optimal therapeutic effects, including anti-inflammatory and immunomodulatory activities, through the PPAR/Notch signaling pathways. Furthermore, ZCH NPs restored the osteogenic potential of stem cells in an inflammatory environment by rebalancing the immune microenvironment. ZCH NPs also eliminated extracellular and intracellular bacteria and inhibited biofilm formation. Ultimately, ZCH NPs alleviated inflammatory bone resorption in rat experimental periodontitis, with the reduction of cementoenamel junction-alveolar bone crest from ~568 to ~250 µm. Therefore, periodontal tissue regeneration was promoted by eradicating pathogenic bacteria, modulating immune response, and facilitating osteogenic differentiation. Collectively, through on-site and responsive drug delivery, ZCH NPs exhibited superior efficacy in treating periodontitis, providing a promising strategy for addressing infection-related chronic inflammatory diseases.
引用
- Jin Y, Du J, Wang Z, et al. Macrophage-Targeted Self-Assembled Nanosystem for Periodontitis Treatment. J Dent Res. 2025. PMID: 41108117. doi:10.1177/00220345251355267
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。